Mirsalis J C, Monforte J A, Winegar R A
SRI International, Toxicology Laboratory, Menlo Park, California 94025-3493, USA.
Annu Rev Pharmacol Toxicol. 1995;35:145-64. doi: 10.1146/annurev.pa.35.040195.001045.
Transgenic rodent models for measuring mutations provide a tool for assessing tissue-specific mutations following in vivo treatment. These systems are based on the insertion into the rodent genome Escherichia coli lacI (lac repressor) or lacZ (beta-galactosidase) genes that serve as targets for mutations. Following in vivo treatment of animals, genomic DNA is isolated from tissues of interest, and the target gene is screened for mutations using either lambda-phage packaging or isolation of the target gene with magnetic affinity capture. In this paper we review the various experimental methods used in the conduct of transgenic mutation assays and discuss critical factors that affect the interpretations of results of these assays.
用于测量突变的转基因啮齿动物模型为评估体内治疗后的组织特异性突变提供了一种工具。这些系统基于将大肠杆菌lacI(乳糖阻遏物)或lacZ(β-半乳糖苷酶)基因插入啮齿动物基因组,这些基因作为突变靶点。在对动物进行体内治疗后,从感兴趣的组织中分离基因组DNA,并使用λ噬菌体包装或通过磁亲和捕获分离靶基因来筛选靶基因的突变。在本文中,我们综述了进行转基因突变分析所使用的各种实验方法,并讨论了影响这些分析结果解释的关键因素。